[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1911 

# __Inadequate vaccine efficacy__

## Category to which it belongs

* [The challenges in vaccination include limited storage capacity, high patient demand, inefficient resource use, distribution difficulties, waning vaccine effectiveness, and unequal access.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_103.md)

## Closest similar item

* [Expectations for vaccine](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_430.md)
* [Inadequate vaccination coverage](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3239.md)
* [Waning efficacy of vaccines](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_861.md)
* [Lack of vaccine or cure](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1748.md)
* [Vaccine availability, Vaccine hesitancy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3168.md)
* [Uncertainty of vaccine effectiveness, time-consuming research process](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3080.md)
* [Vaccine hesitancy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1909.md)
* [Hesitation to vaccinate](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2080.md)
* [Lack of COVID-19 vaccine](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2303.md)
* [Difficulty in vaccine distribution](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_519.md)

## Description of the risk

Waning efficacy of vaccines against re-infections.

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Type of the risk

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Type of impact of the risk (according to ISO37100)

* [Safety and security](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_5.md)

## Type of purpose of the risk (according to ISO37100)

* [Safety and security](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_0.md)

## Mitigations of this risk

* [Improve vaccine efficacy through research and development.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2512.md)

## Name of the risk

Decreased overall protection against COVID-19 re-infections.

## Stakeholders who can mitigate this risk

* [healthcare providers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_121.md)
* [vaccine manufacturers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_1294.md)

## Articles mentionning the risk

* [Contributions to the mitigation of the COVID-19 pandemic](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_245.md)

## People affected by this risk

* [vaccinated individuals](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_1293.md)

## Technologies linked to the risk

* [vaccine development and improvement technologies](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1307.md)

## Property: has_RiskType

* [technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

